glp 1 agonist liver disease Effects of GLP-1 receptor agonists on the degree of fibrosis and CRP in non-alcoholic fatty liver and non-alcoholic steatohepatitis: A systematic review and meta-analysis Mechanisms by which GLP-1 agonists
Description
The SURMOUNT-1 trial showed tirzepatide at 5 mg producing 7.6 kg of weight loss at 40 weeks
doi:10.1055/s-2004-826162 10

Other GLP-1 medications prescribed for type 2 diabetes also support weight loss (albeit not as effectively as these two)

Noda, K

H., Vendruscolo, L

doi: 10.1002/hep.23280
